enrasentan has been researched along with bq 123 in 2 studies
| Studies (enrasentan) | Trials (enrasentan) | Recent Studies (post-2010) (enrasentan) | Studies (bq 123) | Trials (bq 123) | Recent Studies (post-2010) (bq 123) |
|---|---|---|---|---|---|
| 32 | 2 | 0 | 1,391 | 63 | 152 |
| Protein | Taxonomy | enrasentan (IC50) | bq 123 (IC50) |
|---|---|---|---|
| Endothelin-1 receptor | Homo sapiens (human) | 0.017 | |
| Endothelin-1 receptor | Rattus norvegicus (Norway rat) | 0.014 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abraham, WT; Lamba, S; Suresh, DP | 1 |
| Andersen, CU; Laursen, BE; López-Valverde, V; Mulvany, MJ; Simonsen, U | 1 |
1 review(s) available for enrasentan and bq 123
| Article | Year |
|---|---|
New developments in heart failure: role of endothelin and the use of endothelin receptor antagonists.
Topics: Bosentan; Carboxylic Acids; Chronic Disease; Endothelin Receptor Antagonists; Endothelin-1; Heart Failure; Humans; Indans; Peptides, Cyclic; Prognosis; Pyridines; Pyrimidines; Receptors, Endothelin; Sulfonamides; Treatment Outcome | 2000 |
1 other study(ies) available for enrasentan and bq 123
| Article | Year |
|---|---|
Glibenclamide reveals role for endothelin in hypoxia-induced vasoconstriction in rat intrapulmonary arteries.
Topics: Animals; Anti-Arrhythmia Agents; Carboxylic Acids; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelins; Endothelium, Vascular; Enzyme Inhibitors; Glyburide; Hypoxia; In Vitro Techniques; Indans; Male; Nitric Oxide Synthase; Nitroarginine; Oligopeptides; Oxyhemoglobins; Peptides, Cyclic; Phenylephrine; Pinacidil; Piperidines; Pulmonary Artery; Rats; Rats, Wistar; Receptors, Endothelin; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 2005 |